AI Science Tracker

Integrated proteomics and metabolomics with LASSO nominate a four-analyte early IgA-nephropathy plasma panel

Zhejiang Provincial People’s Hospital; and collaborating institutions · 27 Dec 2022 · medicine

Discovery

Integrated proteomics and metabolomics with LASSO nominate a four-analyte early IgA-nephropathy plasma panel

A study of biopsy-confirmed IgA nephropathy (IgAN) integrated plasma proteomics and untargeted metabolomics and used LASSO logistic regression to select PRKAR2A, IL6ST, SOS1 and palmitoleic acid as candidate discriminators from healthy controls. The panel had AUC 0.994 in the training set and 0.977 in the test split; ELISA assays in a separate 9-case/10-control sample set yielded an AUC of 0.91. Proteomic and metabolomic analyses also indicated complement/immune activation and altered energy and amino-acid metabolism in the studied cases.

Technology: LASSO logistic regression (glmnet), with tenfold cross-validation and additional random-forest/SVM model checks

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: A study of biopsy-confirmed IgA nephropathy (IgAN) integrated plasma proteomics and untargeted metabolomics and used LASSO logistic regression to select PRKAR2A, IL6ST, SOS1 and palmitoleic acid as candidate discriminators from healthy controls.
  • Still unknown: This is an early candidate biomarker result, not a validated clinical test or biopsy replacement. The discovery analysis included 33 biopsy-confirmed IgAN cases and 20 healthy controls; the separate ELISA group contained only 9 IgAN cases and 10 controls from the same hospital. The test split is small, and the study did not test specificity against other kidney diseases or demonstrate prospective/clinical utility. The proposed biomarker biology remains speculative.
  • AI role: LASSO feature selection on integrated proteomic and metabolomic measurements nominated the four-analyte panel; the study evaluated its classification in a held-out split and measured the selected analytes by ELISA in an independent sample batch.

Evidence sources: https://link.springer.com/article/10.1186/s12014-022-09387-5

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 40 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.